Phase I, Exploratory, Single Centre, Single oral dose AZD9668 and Intravenous microdose of [C14] AZD9668, Healthy Subject

Study identifier:D0520C00021

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Exploratory Study to Assess the Absolute Bioavailability of a Single Oral Dose of AZD9668 with Respect to an Intra-venous Microdose of [14C]AZD9668 in Healthy Male Subjects

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD9668

Sex

Male

Actual Enrollment

Study type

Interventional

Age

18 Years - 65 Years

Date

Study Start Date: 01 Jun 2010

Primary Completion Date: 01 Jun 2010

Study Completion Date: 01 Jun 2010

Study design

Allocation: Non-randomized
Endpoint Classification: Bio-availability Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

Location

Research Site

RUDDINGTON, NOTTINGHAM, United Kingdom

Location

Research Site

LONDON, United Kingdom

Arms	Assigned Interventions
Experimental: AZD9668 Tablets and intravenous (IV) dose	Drug: AZD9668 Tablets of AZD9668 and IV dose of [C14]AZD9668

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1655&filename=CSR-D0520C00021.pdf
Download
CSR-D0520C00021.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

Quintiles London

+ 44 0800 634 1132

Investigators

Principal Investigator

Joanna Marks-Konczalik

AstraZeneca

Phase I, Exploratory, Single Centre, Single oral dose AZD9668 and Intravenous microdose of [C14] AZD9668, Healthy Subject

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Research Site

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1655&filename=CSR-D0520C00021.pdf

CSR-D0520C00021.pdf

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator